Do user preferences align with human factors assessment scores of drug–drug interaction alerts?

Author:

Lowenstein David1ORCID,Zheng Wu Yi2,Burke Rosemary3,Kenny Eliza4,Sandhu Anmol5,Makeham Meredith,Westbrook Johanna2,Day Richard O6,Baysari Melissa T7

Affiliation:

1. UNSW Sydney, Australia

2. Macquarie University, Australia

3. Concord Repatriation General Hospital, Australia

4. Macquarie University Hospital, Australia

5. St Vincent’s Hospital, Sydney, Australia

6. UNSW Sydney, Australia; St Vincent’s Hospital, Sydney, Australia

7. Macquarie University, Australia; UNSW Sydney, Australia

Abstract

This study aimed to assess drug–drug interaction alert interfaces and to examine the relationship between compliance with human factors principles and user-preferences of alerts. Three reviewers independently evaluated drug–drug interaction alert interfaces in seven electronic systems using the Instrument-for-Evaluating-Human-Factors-Principles-in-Medication-Related-Decision-Support-Alerts (I-MeDeSA). Fifty-three doctors and pharmacists completed a survey to rate the alert interfaces from best to worst and reported on liked and disliked features. Human factors compliance and user-preferences of alerts were compared. Statistical analysis revealed no significant association between I-MeDeSA scores and user-preferences. However, the strengths and weaknesses of drug–drug interaction alerts from users’ perspectives were in-line with the human factors constructs evaluated by the I-MeDeSA. I-MeDeSA in its current form, is unable to identify alerts that are preferred by the users. The design principles assessed by I-MeDeSA appear to be sound, but its arbitrary allocation of points to each human factors construct may not reflect the relative importance that the end-users place on different aspects of alert design.

Funder

National Health and Medical Research Council Program

Publisher

SAGE Publications

Subject

Health Informatics

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3